[Form 4] Equifax, Incorporated Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Insider Trade Summary
Net Seller: 48,264 shares ($11,666,013)
Net Sell
13 txns
Insider
Begor Mark W
Role
CEO
Sold
48,264 shs ($11.67M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option/Right to Buy | 27,960 | $0.00 | -- |
| Exercise | Common Stock | 27,960 | $191.44 | $5.35M |
| Sale | Common Stock | 364 | $244.9479 | $89K |
| Sale | Common Stock | 831 | $243.9032 | $203K |
| Sale | Common Stock | 9,497 | $242.7014 | $2.30M |
| Sale | Common Stock | 17,731 | $241.8713 | $4.29M |
| Sale | Common Stock | 19,841 | $240.9462 | $4.78M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option/Right to Buy — 27,959 shares (Direct);
Common Stock — 191,136 shares (Direct);
Common Stock — 10,500 shares (Indirect, 2-yr 2025 GRAT)
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $244.72 to $245.33, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $243.47 to $244.44, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $242.41 to $243.17, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $241.41 to $242.40, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $240.40 to $241.39, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. The option vested in three equal annual increments beginning 2/21/2021.
